Effects of a Time Restricted Eating Protocol on Cyclists (TRECYC)
Study Details
Study Description
Brief Summary
We sought to investigate the effects of 4 weeks of 16/8 time restricted eating (TRE) with windows of 16 hours of fasting and 8 hours of eating) on elite cyclists' performance, metabolic and blood parameters.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Sixteen elite under-23 cyclists were randomly assigned to a TRE group or to a control group (CTRL) with a traditional meal pattern. The TRE group consumed 100% of its estimated daily energy needs in an 8-hour time window: from 10:00 AM (ante meridiem) to 6:00 PM (post meridiem) whilst the CTRL group consumed 100% of its estimated daily energy needs in 3 meals between 7:00 AM and 9:00 PM. During the experimental period, training loads were similar in the two groups. Athletes were tested before and after 4 weeks of the intervention. Body composition , basal metabolism, performances indexes and blood parameters were measured.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Time restricted eating (TRE) TRE group consumed 100% of its estimated daily energy needs in an 8-hour time window: from 10:00 AM to 6:00 PM |
Other: Time restricted eating
TRE group consumed 100% of its estimated daily energy needs in an 8-hour time window: from 10:00 AM to 6:00 PM
Other Names:
|
Active Comparator: Control (CTRL) CTRL group consumed 100% of its estimated daily energy needs in 3 meals between 7:00 AM and 9:00 PM |
Other: Control
CTRL group consumed 100% of its estimated daily energy needs in 3 meals between 7:00 AM and 9:00 PM
Other Names:
|
Outcome Measures
Primary Outcome Measures
- VO2max [4 weeks]
Maximal oxygen consumption (in ml O2/Kg/min) measured during a cycloergometer incremental test through a gas analyses
- fat mass [4 weeks]
fat mass measured through body impedence analyser
- lean body mass [4 weeks]
lean body mass mass measured through body impedence analyser
Secondary Outcome Measures
- white blood cells [4 weeks]
white blood cells as thousands per microliter
- Eosinophils [4 weeks]
Eosinophils as percentage of total white blood cells
- Monocytes [4 weeks]
Monocytes as percentage of total white blood cells
- Basophiles [4 weeks]
Basophiles s percentage of total white blood cells
- Hematocrit [4 weeks]
Hematocrit as percentage
- Haemoglobin [4 weeks]
Haemoglobin as gram per Liter
- Mean cell volume [4 weeks]
mean cell volume as femtonLiter
- mean cell haemoglobin [4 weeks]
mean cell haemoglobin as picograms
- ESR (Erythrocyte sedimentation rate ) [4 weeks]
ESR as millimeters per hour
- CRP (C-reactive protein) [4 weeks]
CRP as milligram per deciliter
- Total cholesterol [4 weeks]
Total cholesterol as milligram per deciliter
- TG (triglycerides) [4 weeks]
TG as milligram per deciliter
- glucose [4 weeks]
glucose as milligram per deciliter
- creatinine [4 weeks]
creatinine as milligram per deciliter
- creatin kinase [4 weeks]
creatin kinase as milligram per deciliter
- iron [4 weeks]
iron as microgram per deciliter
- ferritin [4 weeks]
ferritin as microgram per liter
- transferrin [4 weeks]
ferritin as milligram per deciliter
- TSH (Thyroid Stimulating Hormone) [4 weeks]
TSH as micro international unit per milliliter
- T3 (triiodothyronine) free [4 weeks]
T3 free as picogram per milliliter
- Testosterone free [4 weeks]
Testosterone free as picogram per milliliter
- IL-6 [4 weeks]
IL-6 as picogram per milliliter
- TNFalfa [4 weeks]
TNFalfa as picogram per milliliter
- IGF-1 [4 weeks]
IGF-1 as nanogram per milliliter
- Insulin [4 weeks]
Insulin micro international unit per milliliter
Eligibility Criteria
Criteria
Inclusion Criteria:
- elite under 23 cyclists male
Exclusion Criteria:
-
adherence to special diets
-
use of nutritional supplements (except a daily multivitamin-mineral and/or protein supplement)
-
use of medications
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Nutrition and Exercise Lab, DSB, University of Padova | Padova | Italy | 35131 |
Sponsors and Collaborators
- University of Padova
- University of Palermo
- University of Pavia
Investigators
- Principal Investigator: Antonio Paoli, MD, University of Padova
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- AP1019